Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-prostatic Botox injection for benign prostatic hyperplasia
IRCT20190813044522N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of botulinum toxin type A in benign prostatic hyperplasia (BPH), sponsored by Mashhad University of Medical Sciences. Started May 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on IRCT20190813044522N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190813044522N1.